Paper38829482
Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B.
Noor S and 8 others. Mol Cell Biochem, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B. Papers, record 38829482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38829482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Investigating the chemo-preventive role of noscapine in lung carcinoma via therapeutic targeting of human aurora kinase B.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aurora Kinase B | Major topic |
| Noscapine | Major topic |
| Lung Neoplasms | Major topic |
| Neoplasm Proteins | Major topic |
| Protein Kinase Inhibitors | Major topic |
| Humans | |
| A549 Cells | |
| Molecular Docking Simulation |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R.12014/60/2022-HR | Indian Council of Medical Research | PubMed | ||
| Researchers Supporting Project Number (RSPD2024R980) | King Saud University | PubMed |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28830777 | Biological evaluation of p-toluene sulphonylhydrazone as carbonic anhydrase IX inhibitors: An approach to fight hypoxia-induced tumors. | Int J Biol Macromol | 2018 | https://conductscience.org/library/papers/28830777 | PubMed |
| 2 | 21423660 | Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer. | PLoS One | 2011 | https://conductscience.org/library/papers/21423660 | PubMed |
| 3 | 27496133 | Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo. | Mol Cancer Ther | 2016 | https://conductscience.org/library/papers/27496133 | PubMed |
| 4 | 17893514 | Apoptotic pathway induced by noscapine in human myelogenous leukemic cells. | Anticancer Drugs | 2007 | https://conductscience.org/library/papers/17893514 | PubMed |
| 5 | 37141737 | Biochemical features and therapeutic potential of α-Mangostin: Mechanism of action, medicinal values, and health benefits. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37141737 | PubMed |
| 6 | 32422877 | Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy. | Biomedicines | 2020 | https://conductscience.org/library/papers/32422877 | PubMed |
| 7 | 26638998 | Aurora-B and HDAC synergistically regulate survival and proliferation of lymphoma cell via AKT, mTOR and Notch pathways. | Eur J Pharmacol | 2016 | https://conductscience.org/library/papers/26638998 | PubMed |
| 8 | 36851679 | Global Lipidome Profiling Revealed Multifaceted Role of Lipid Species in Hepatitis C Virus Replication, Assembly, and Host Antiviral Response. | Viruses | 2023 | https://conductscience.org/library/papers/36851679 | PubMed |
| 9 | 31343173 | Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4. | J Nat Prod | 2019 | https://conductscience.org/library/papers/31343173 | PubMed |
| 10 | 34445523 | Aurora B Tension Sensing Mechanisms in the Kinetochore Ensure Accurate Chromosome Segregation. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445523 | PubMed |
| 11 | 19626589 | Non-toxic melanoma therapy by a novel tubulin-binding agent. | Int J Cancer | 2010 | https://conductscience.org/library/papers/19626589 | PubMed |
| 12 | 18032922 | VX-680 inhibits Aurora A and Aurora B kinase activity in human cells. | Cell Cycle | 2007 | https://conductscience.org/library/papers/18032922 | PubMed |
| 13 | 34054126 | Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/34054126 | PubMed |
| 14 | 24057926 | Thymol inhibits LPS-stimulated inflammatory response via down-regulation of NF-κB and MAPK signaling pathways in mouse mammary epithelial cells. | Inflammation | 2014 | https://conductscience.org/library/papers/24057926 | PubMed |
| 15 | 31273958 | Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway. | Cancer Med | 2019 | https://conductscience.org/library/papers/31273958 | PubMed |
| 16 | 30259761 | A comprehensive review of protein kinase inhibitors for cancer therapy. | Expert Rev Anticancer Ther | 2018 | https://conductscience.org/library/papers/30259761 | PubMed |
| 17 | 34448628 | Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase. | OMICS | 2021 | https://conductscience.org/library/papers/34448628 | PubMed |
| 18 | 27285995 | Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade. | PLoS One | 2016 | https://conductscience.org/library/papers/27285995 | PubMed |
| 19 | 32905276 | Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer. | ACS Omega | 2020 | https://conductscience.org/library/papers/32905276 | PubMed |
| 20 | 34303039 | Identification of novel anti-cancer agents by the synthesis and cellular screening of a noscapine-based library. | Bioorg Chem | 2021 | https://conductscience.org/library/papers/34303039 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42415924 | ZnO@PDA@Ag nanocomposite-mediated delivery of 9-bromonoscapine, an anticancer agent, for enhanced lung cancer therapy. | Nanoscale Adv | 2026 | https://conductscience.org/library/papers/42415924 | PubMed |
| 40453822 | Exploring anticancer activity of baicalin, naringenin, and noscapine via binding and inhibition of sphingosine kinase 1. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40453822 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AURKB | 9212 | PubTator's text mining | https://conductscience.org/library/genes/9212 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38829482
GET https://conductscience.org/api/papers/v1/38829482/references?page=2